Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00144521
Status:
COMPLETED
Last Update Posted:
2009-02-02
First Post:
2005-09-02
Brief Title:
Comparative Study Double-Blind of MRA for Rheumatoid Arthritis RA
Sponsor:
Chugai Pharmaceutical
Organization:
Chugai Pharmaceutical
Study Overview
Official Title:
A Double-Blind Phase III Study to Evaluate the Efficacy and Safety of MRA in Patients With RA
Status:
COMPLETED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the clinical efficacy and safety of MRA in a double-blind parallel-group controlled study using MRA or methotrexate MTX in rheumatoid arthritis RA patients with MTX administered
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None